Legend Biotech Ownership | Who Owns Legend Biotech?
Legend Biotech Ownership Summary
Legend Biotech is owned by 14.81% institutional investors, 1.31% insiders, and 83.88% retail investors. Fmr is the largest institutional shareholder, holding 13.91% of LEGN shares. Fidelity OTC is the top mutual fund, with 2.53% of its assets in Legend Biotech shares.
LEGN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Legend Biotech | 14.81% | 1.31% | 83.88% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 25.70M | 13.91% | $464.85M |
| Deerfield management company, l.p. (series c) | 7.69M | 4.16% | $139.07M |
| Suvretta capital management | 7.58M | 4.10% | $137.14M |
| Hhlr advisors | 5.98M | 3.24% | $108.26M |
| Blackrock | 5.72M | 3.14% | $253.40M |
| Westfield capital management co lp | 5.76M | 3.12% | $104.26M |
| Blackrock funding, inc. /de | 4.68M | 2.54% | $84.74M |
| Point72 asset management | 3.89M | 2.10% | $70.30M |
| First beijing investment | 2.30M | 1.24% | $41.54M |
| Artisan partners limited partnership | 2.25M | 1.22% | $40.78M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ivyrock asset management (hk) | 804.00K | 8.17% | $14.54M |
| Matthews capital management | 925.92K | 6.80% | $16.75M |
| Davern capital partners, lp | 1.31M | 6.52% | $23.78M |
| Hhlr advisors | 5.98M | 6.47% | $108.26M |
| Suvretta capital management | 7.58M | 3.50% | $137.14M |
| Patient square capital lp | 990.00K | 3.18% | $17.91M |
| Johnson & johnson | 814.59K | 2.26% | $14.74M |
| Allostery investments lp | 4.00K | 1.81% | $141.96K |
| First beijing investment | 2.30M | 1.79% | $41.54M |
| Kynam capital management, lp | 1.58M | 1.76% | $28.52M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| First beijing investment | 2.30M | 1.79% | 2.30M |
| Deerfield management company, l.p. (series c) | 7.69M | 1.64% | 1.76M |
| Kynam capital management, lp | 1.58M | 1.76% | 1.58M |
| Fmr | 25.70M | 0.02% | 1.43M |
| Two sigma investments, lp | 1.89M | 0.03% | 1.36M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -7.51M |
| Capital world investors | - | - | -2.39M |
| Wellington management group llp | - | - | -1.86M |
| Alliancebernstein | - | - | -1.52M |
| Braidwell lp | - | - | -1.30M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| First beijing investment | 2.30M | 1.79% | 2.30M | $41.54M |
| Kynam capital management, lp | 1.58M | 1.76% | 1.58M | $28.52M |
| Patient square capital lp | 990.00K | 3.18% | 990.00K | $17.91M |
| Rakuten investment management | 232.47K | 0.02% | 232.47K | $6.60M |
| Y-intercept (hong kong) | 223.30K | 0.08% | 223.30K | $4.04M |
Sold Out
| Holder | Change |
|---|---|
| Larson financial group | -2.00 |
| Abound wealth management | -4.00 |
| Cva family office | -15.00 |
| Smartleaf asset management | -21.00 |
| Parkside financial bank & trust | -23.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 119 | -44.65% | 27,360,336 | -68.76% | 14 | 0.16% | 63 | -40.57% | 30 | -53.13% |
| Dec 31, 2025 | 139 | -35.65% | 28,301,091 | -66.19% | 31 | 0.38% | 66 | -40.00% | 41 | -28.07% |
| Sep 30, 2025 | 208 | -7.56% | 83,554,687 | -1.27% | 90 | 4.30% | 104 | -4.59% | 57 | -32.94% |
| Jun 30, 2025 | 224 | 2.75% | 84,632,757 | -1.43% | 45 | 2.11% | 108 | 5.88% | 85 | 10.39% |
| Mar 31, 2025 | 221 | -1.78% | 86,577,050 | -12.78% | 47 | 1.59% | 104 | -20.00% | 78 | 39.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity OTC | 4.68M | 2.53% | - |
| Invesco Emerging Markets Equity | 2.69M | 1.46% | -277.61K |
| Invesco Developing Markets A | 2.69M | 1.46% | - |
| Fidelity Select Health Care | 2.60M | 1.41% | -200.00K |
| Fidelity Select Pharmaceuticals Port | 2.52M | 1.36% | -76.10K |
| Fidelity Growth Compy Commingled Pl O | 2.43M | 1.32% | - |
| T. Rowe Price US Growth Stock Composite | 2.32M | 1.26% | -77.22K |
| T. Rowe Price Growth Stock | 2.27M | 1.24% | -32.51K |
| Fidelity VIP Contrafund Initial | 2.14M | 1.16% | - |
| Jupiter Merian Glb Eq AbsRet I USD Acc | 2.09M | 1.13% | 2.09M |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 25, 2026 | Huang Ying | Chief Executive Officer | Sell | $87.14K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 1 |
LEGN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools